NIH / NCI / CC/ NIBIB
Dr. Wood is Director of the NIH Center for Interventional Oncology & Chief of Intervetnional Radiology, where he has practiced and led a team of scientists, physician scientists and students for many years, with global academic and industry partnerships. The Center for Interventional Oncology translates technologies and paradigms for first-in-human treatments for cancer and cultivates interventional radiology applications within a muliti-disciplinary framework, to apply biomedical engineering to meet real-life unmet clinical needs.
His team’s achievements include helping to pioneer several technologies from concept to bench to patient, and his team was “first- -in-human” for the following device/drug combinations: prostate cancer MRI/TRUS fusion biopsy and ablation, image-able iodinated drug eluting beads for embolization or chemoembolization, heat deployed nano-chemotherapy combined with thermal ablation for liver cancer, “medical GPS” electromagnetic (EM) tracking for fusion of ultrasound to CT, MR, and PET, and fusion for needle-based procedures like biopsy and thermal ablation, and kidney and adrenal tumor ablation. The NIH team has performed over 40,000 needle procedures in over 2500 patients with tracking and fusion technology, which has become a standard of care worldwide. The NCI liver cancer team was also the first to combine check point immunotherapies with local and regional image-guided thermal ablation or chemo-embolization for liver and biliary tract cancers in clinical trials. Dr Wood has mentored hundreds of students, fellows, physicians, nurses, and scientists. His team's success has led to an H-index of 79, and he has co-authored > 50 patents, > 500 peer-reviewed papers, and several books on radiology and interventional urology. Teamwork breeds team success.